TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
INCY

Incyte Corporation

Healthcare · Biotechnology

125.30$ -1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Incyte Corporation (INCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 1,413 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow INCY
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
26 87 305 -93 336 711 -125 749 970 496 335 1,413
41 45 58 52 55 55 52 58 68 83 89 93
62 70 96 133 148 167 178 183 188 216 266 249
62 73 117 226 174 186 201 -266 275
-29 -35 25 -64 -47 57 -72 -15 199 -249 138 -527
28 26 120 111 73 78 187 181 78 47 86 59
-138 -105 -232 -350 -86 -87 -269 -208 -79 -208 158 -103
0.0 0.0 0.0 0.0 17 23 30 26
93 86 50 716 30 -17 -23 -30 -26 -29 -2,005 -19
0.2 -1.7 14 0.0 -0.8 -0.8 -0.8 -2.4 -2.9 -3.4 -3.8 -4.5
93 88 59 690 15 46 72 6.2 -0.8 -20 -2,022 101
-19 69 131 247 265 669 -319 544 894 262 -1,526 1,410
-1.6 61 184 -204 263 633 -312 568 892 449 249 1,355

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?